知镜 Cognispect · 医学文献与研究工作台

Unveiling the role of p53 in the pathogenesis and treatment of autoimmune rheumatic diseases.

Akbarzadeh F, Farhadi E, Vodjgani M, Jamshidi A, Mahmoudi M.
Molecular biology reports · 2026-08-28 · PMID 42663787

文献摘要

p53 is a master transcription factor best known for its tumor-suppressing properties. However, its significance extends beyond cancer to the pathogenesis of autoimmune diseases. In addition to its classic effects on the cell cycle and apoptosis, mounting evidence reveals that p53 exerts various non-classical functions, including regulating immunological responses, inflammation, angiogenesis, fibrosis, and other programmed cell death modalities such as ferroptosis. Thus, p53 is critical for maintaining homeostasis and immune tolerance. Dysregulations of p53, including altered expression and mutations in individuals with autoimmune diseases, may contribute to aberrant immune responses, chronic inflammation, organ damage, and disease progression. In this review, we first briefly discuss the canonical and non-canonical functions of p53 and then explore these functions in autoimmune rheumatic disorders. The aim is to illuminate underexplored areas to guide future research that will enhance our understanding of the pathogenesis of these diseases, focusing on rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc). Lastly, we will discuss the potential of p53-based therapies, such as p53 activators, to restore normal p53 activity in autoimmune diseases, which could transform treatment options for these chronic and refractory conditions.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。